Oric Pharma grants 39,200 stock options, 6,400 RSUs to new employees under inducement plan

Oric Pharmaceuticals granted 39,200 non-qualified stock options and 6,400 restricted stock units to two new non-executive employees on Sept. 1, 2026.

• The stock options were priced at the common stock closing price on the grant date.
• The options vest 25% after one year, then monthly in equal installments over the next 36 months.
• The restricted stock units vest in three equal tranches on the first three anniversaries of the grant date.